Product Information
RIFABUTIN 150 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $9.0755 per EA under NDC 59762135001. Its NADAC has been published 345 times since Nov 19, 2014.
Strength
150 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762135001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIFABUTINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050689On Market Since
4/7/2014
Pharmacological Classes
Price Statistics
The NADAC for RIFABUTIN 150 MG CAPSULE has been published 345 times since Nov 19, 2014, and over the history we have for it it has declined 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0755 per EA |
|---|---|
| All-time high | $13.7705 (Jul 15, 2015) |
| All-time low | $7.3273 (Jun 19, 2024) |
| 52-week high | $9.7795 |
| 52-week low | $8.7331 |
| Median price | $11.9592 |
| Average price | $11.2837 |
| Largest weekly change | -18.0% (May 22, 2024) |
| Weeks tracked | 345 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the rifabutin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RIFABUTIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFABUTIN 150 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $9.0755 per EA (NDC 59762135001), effective Jun 24, 2026.
How has the price of RIFABUTIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFABUTIN 150 MG CAPSULE has declined 31.3%. It has been tracked across 345 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for RIFABUTIN 150 MG CAPSULE?
Since Nov 19, 2014, the NADAC for RIFABUTIN 150 MG CAPSULE has ranged from a low of $7.3273 (Jun 19, 2024) to a high of $13.7705 (Jul 15, 2015), with a median of $11.9592 per EA.
Are there cheaper alternatives to RIFABUTIN 150 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RIFABUTIN 150 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures RIFABUTIN 150 MG CAPSULE?
RIFABUTIN 150 MG CAPSULE (NDC 59762135001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification